Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells $47,305.50 in Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Angelita Rebamontan Domingo sold 2,585 shares of the firm’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $18.30, for a total value of $47,305.50. Following the completion of the transaction, the director now directly owns 8,191 shares of the company’s stock, valued at $149,895.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Pro-Dex Trading Up 3.9 %

Shares of Pro-Dex stock opened at $19.64 on Friday. The company’s 50-day moving average price is $19.09 and its 200-day moving average price is $18.67. The company has a current ratio of 3.45, a quick ratio of 2.08 and a debt-to-equity ratio of 0.25. Pro-Dex, Inc. has a 12-month low of $14.51 and a 12-month high of $22.99. The company has a market cap of $67.17 million, a price-to-earnings ratio of 33.86 and a beta of 0.41.

Pro-Dex (NASDAQ:PDEX) last posted its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.19 earnings per share (EPS) for the quarter. Pro-Dex had a net margin of 4.13% and a return on equity of 6.50%. The business had revenue of $14.29 million for the quarter.

Institutional Investors Weigh In On Pro-Dex

A hedge fund recently raised its stake in Pro-Dex stock. Perritt Capital Management Inc. boosted its holdings in Pro-Dex, Inc. (NASDAQ:PDEX) by 43.3% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,000 shares of the medical instruments supplier’s stock after acquiring an additional 1,813 shares during the quarter. Perritt Capital Management Inc. owned 0.18% of Pro-Dex worth $106,000 at the end of the most recent reporting period. Institutional investors own 15.28% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com raised Pro-Dex from a “buy” rating to a “strong-buy” rating in a report on Wednesday, June 5th.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.